BioVersys AG (XSWX:BIOV) Retained Earnings: CHF-101.13 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:BIOV BioVersys AG XSWX:BIOV
4 GF Score
Price CHF26.90
View Full Analysis

What is BioVersys AG Retained Earnings?

BioVersys AG XSWX:BIOV -2.89% 4 Retained Earnings is CHF-101.13 Mil as of Dec. 2025. GuruFocus rates XSWX:BIOV with a GF Score™ of 4/100.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. BioVersys AG's retained earnings for the quarter that ended in Dec. 2025 was CHF-101.13 Mil.

BioVersys AG's quarterly retained earnings declined from Dec. 2024 (CHF-80.34 Mil) to Jun. 2025 (CHF-90.95 Mil) and declined from Jun. 2025 (CHF-90.95 Mil) to Dec. 2025 (CHF-101.13 Mil).

BioVersys AG's annual retained earnings increased from . 20 (CHF0.00 Mil) to Dec. 2024 (CHF-80.34 Mil) but then declined from Dec. 2024 (CHF-80.34 Mil) to Dec. 2025 (CHF-101.13 Mil).


BioVersys AG  (XSWX:BIOV) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


BioVersys AG Retained Earnings Historical Data

* Premium members only.

The historical data trend for BioVersys AG's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioVersys AG Retained Earnings Chart

BioVersys AG Annual Data
Trend Dec24 Dec25
Retained Earnings
-80.34 -101.13

BioVersys AG Semi-Annual Data
Jun24 Dec24 Jun25 Dec25
Retained Earnings 0.00 -80.34 -90.95 -101.13
XSWX:BIOV
4GF Score
BioVersys AG XSWX:BIOV
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioVersys AG Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of CHF-101.13 Mil mean?
BioVersys AG (XSWX:BIOV) has a Retained Earnings of CHF-101.13 Mil as of Dec. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on BioVersys AG and its competitors.
Is BioVersys AG's Retained Earnings too high?
BioVersys AG's current Retained Earnings is CHF-101.13 Mil. Overall, BioVersys AG has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does BioVersys AG's Retained Earnings compare to VRTX and REGN?
BioVersys AG's Retained Earnings of CHF-101.13 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on BioVersys AG and its competitors. BioVersys AG's current Retained Earnings is CHF-101.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioVersys AG stock overvalued right now?
BioVersys AG (XSWX:BIOV) has a current Retained Earnings of CHF-101.13 Mil. The current Retained Earnings is CHF-101.13 Mil. BioVersys AG's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For BioVersys AG (XSWX:BIOV), the current Retained Earnings is CHF-101.13 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioVersys AG Business Description

Other Exchanges BIOVz:UKW33:Germany
Address c/o Technologiepark, Hochbergerstrasse 60c, Basel, CHE, CH-4057
BioVersys AG is a multi-asset, clinical-stage biopharmaceutical company. The Group focuses on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The pipeline products of the company include BV100 - novel MoA, Alpibectir - novel potentiator MoA, BV200 - novel anti-virulence MoA, BV500 - novel series, and others. It has one operating segment focusing on the research and development and prospective commercialization of antibiotics. Geographically, the company operates in Switzerland and France.
4GF Score

Get the complete analysis for XSWX:BIOV

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF26.90
Price